Related Experiment Video
Updated: Jun 24, 2026

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
Published on: June 27, 2025
Relationship between decrease in ambulatory blood pressure and heart rate variability due to the effects of taking
Taiji Furukawa1, Taketo Hatsuno, Yasunari Ueno
1Department of Internal Medicine, School of Medicine, Teikyo University, Teikyo, Japan.
Insights
Olmesartan demonstrated superior blood pressure reduction compared to candesartan in patients with essential hypertension. This antihypertensive drug therapy did not induce significant changes in heart rate variability.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Management
Background:
- Olmesartan is an angiotensin receptor blocker (ARB) with reported high clinical efficacy.
- Essential hypertension management often involves ARBs like olmesartan and candesartan.
Purpose of the Study:
- To compare the clinical efficacy of olmesartan versus candesartan in treating essential hypertension.
- To evaluate the impact of switching from candesartan to olmesartan on blood pressure and heart rate variability.
Main Methods:
- A study involving 31 patients with essential hypertension.
- Measurements included Holter electrocardiogram, ambulatory blood pressure monitoring, and pulse wave velocity (PWV).
- Patients switched from candesartan 8 mg to olmesartan 20 mg.
Main Results:
- Olmesartan significantly reduced systolic and diastolic blood pressure (6.7/3.6 mmHg average decrease).
- Pulse wave velocity (PWV) was also significantly decreased.
- No significant alterations in heart rate variability spectral components (VLF, HF, LF/HF) were observed, though LF/HF correlated with blood pressure changes.
Conclusions:
- Olmesartan exhibits a stronger antihypertensive effect than candesartan.
- Olmesartan therapy does not appear to generate reflex sympathoexcitatory activity.
Unlabelled:
BACKGROUNDS AND METHODS: A higher degree of clinical efficacy with olmesartan compared with other angiotensin receptor blockers, has been reported by several sources. In this study of 31 examples of cases of essential hypertension, Holter electrocardiogram, ambulatory blood pressure monitoring and pulse wave velocity (PWV) measurements were performed before and after substituting olmesartan 20 mg for candesartan 8 mg antihypertensive drug therapy.
Results:
Following the therapeutic change, daily average systolic and diastolic blood pressures were decreased by 6.7 +/- 9.3 mmHg and 3.6 +/- 8.3 mmHg, respectively, with olmesartan 20 mg; PWV was also significantly decreased. Holter electrocardiogram heart rate variability spectral analysis demonstrated that none of the very low frequency (VLF), high frequency (HF) and low frequency (LF)/HF components were significantly altered. However, a significant correlation was observed between the LF/HF component and blood pressure difference, when blood pressure and heart rate variability components in each individual case were studied.
Conclusion:
This study shows that olmesartan has a stronger antihypertensive effect in comparison to candesartan, and does not generate reflex sympathoexcitatory activity.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...